Fund access to GLP-1 medications through the NHS for women with PCOS

Studies highlight the effectiveness of GLP-1 medications for women with PCOS. We think funding access to GLP-1 treatments, without restrictive BMI criteria or tier system barriers, would improve care and outcomes for these patients.

828 Signatures

Status
Open
Opened
Tuesday 14th January 2025
Last 24 hours signatures
5
Signature Deadline
Monday 14th July 2025
Estimated Final Signatures: 838

Reticulating Splines

You may be interested in these active petitions

1. Fund a National NHS Railcard for Healthcare Staff - 2,434 signatures
2. Fund more Physician Associates roles in the NHS - 4,376 signatures
3. Fund a full bursary and maintenance fund to train Learning Disability Nurses - 2,502 signatures
4. Increase funding for transgender healthcare to reduce waiting times & train GPs - 6,298 signatures
5. Provide funding to support Breast & Cervical Cancer Screening for Disabled Women - 3,223 signatures

Studies reveal that women with PCOS have higher absenteeism, increased unemployment, and a greater risk of disability retirement by age 52.

Without effective preventive treatments like GLP-1, we think there is a greater burden on the NHS due to downstream complications of untreated PCOS later on. This can include diabetes, cardiovascular disease, infertility, mental health issues, and cancer.

We think early intervention is essential to reduce these long-term healthcare costs on the NHS.


Petition Signatures over time

Constituency Data

Reticulating Splines